GEN — Genomed SA Income Statement
0.000.00%
Last trade - 00:00
- PLN39.11m
- PLN33.86m
- PLN22.48m
- 87
- 23
- 10
- 31
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | PAS | PAS | PAS | PAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 19.7 | 18.8 | 19.9 | 20.5 | 22.5 |
Cost of Revenue | |||||
Gross Profit | 7.2 | 6.61 | 7.78 | 7.81 | 9.63 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 18.6 | 18.3 | 18.6 | 20.1 | 21 |
Operating Profit | 1.1 | 0.468 | 1.34 | 0.357 | 1.43 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.08 | 0.409 | 1.33 | 0.369 | 1.24 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1 | 0.412 | 1.24 | 0.338 | 0.992 |
Net Income Before Extraordinary Items | |||||
Net Income | 1 | 0.412 | 1.24 | 0.338 | 0.992 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1 | 0.412 | 1.24 | 0.338 | 0.992 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.743 | 0.312 | 0.937 | 0.256 | 0.75 |
Dividends per Share |